2022
DOI: 10.1016/j.jad.2022.02.071
|View full text |Cite
|
Sign up to set email alerts
|

Direct medical cost of bipolar disorder: Insights from the FACE-BD longitudinal cohort

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…However, the costs could be dropped by more than 50% based on two-year follow-up observations for the subgroup with skilled nursing treatment. 82 Notably, in addition to the cost of treatment, impaired academic performance, unemployment, loss of productivity, and reduced interpersonal interactions due to symptoms and cognitive impairment also impose incalculable financial costs on patients. 83 …”
Section: Family Functioningmentioning
confidence: 99%
“…However, the costs could be dropped by more than 50% based on two-year follow-up observations for the subgroup with skilled nursing treatment. 82 Notably, in addition to the cost of treatment, impaired academic performance, unemployment, loss of productivity, and reduced interpersonal interactions due to symptoms and cognitive impairment also impose incalculable financial costs on patients. 83 …”
Section: Family Functioningmentioning
confidence: 99%
“…Relapses cause crises for patients, their families, healthcare services and society. There is evidence that specialist treatment may be effective in terms of reducing relapses, improving quality of life, and reducing health care costs (5). This includes psychoeducation for cases and their families which, as an adjunct strategy to pharmacotherapy in the treatment of BD leads to a reduction in the frequency of relapse, length of hospital stays, and better adherence to drug therapy (6).…”
mentioning
confidence: 99%